Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
View Patent ↗The present invention provides an oral preventive or therapeutic agent for skin damage, containing diacylglyceryl ether as an active ingredient represented by the formula (I): wherein R 1 denotes C 12-24 aliphatic hydrocarbon group having a degree of unsaturation of between 0 and 2; R 2 denotes C 12-24 acyl group having a degree of unsaturation of between 0 and 6; and R 3 denotes C 12-24 acyl group having a degree of unsaturation of between 0 and 6.
1. A method of reducing at least one skin damage in a subject in need thereof, comprising orally administering to the subject in need thereof a composition comprising diacylglyceryl ether represented by the formula (I), triglyceride, and squalene; in an-amount sufficient to reduce the at least one skin damage:
wherein R 1 denotes C 12-24 aliphatic hydrocarbon group having a degree of unsaturation of between 0 and 2; R 2 denotes C 12-24 acyl group having a degree of unsaturation of between 0 and 6; and R 3 denotes C 12-24 acyl group having a degree of unsaturation of between 0 and 6, and
wherein the at least one skin damage is selected from the group consisting of formation of skin cancer induced by ultraviolet light, formation of pigmented spots induced by ultraviolet light, formation of freckles induced by ultraviolet light, the formation of wrinkles induced by ultraviolet light, the formation of verrucae induced by ultraviolet light, and the formation of erythema induced by ultraviolet light.
2. The method of claim 1 , wherein the diacylglyceryl ether, in the composition, is orally administered at a dosage of between 10 mg and 5000 mg per day.
3. The method of claim 1 , wherein the composition is provided in the form of a processed food.
4. The method of claim 1 , wherein the diacylglyceryl ether, in the composition, is orally administered at a dosage of between 100 mg and 2000 mg per day.
5. The method of claim 1 , wherein the at least one diacylglyceryl ether, in the composition, is orally administered at a dosage of between 500 mg and 2000 mg per day.
6. The method of claim 1 , wherein the composition is provided in liquid form.
7. The method of claim 6 , wherein the liquid form is a suspension, emulsion, syrup, or elixir.
8. The method of claim 1 , wherein the composition is provided in the form of a tablet, sustained-release tablet, granule, fine-grained agent, chewable tablet, sublingual tablet, or gum.
9. The method of claim 1 , wherein the oral administering is carried out once a day or at several separate instances a day.
10. The method of claim 1 , wherein the composition further comprises at least one further component selected from the group consisting of an excipient, a binder, a disintegrating agent, a surfactant, a lubricant, an agent for promoting flowability, a pH regulator, an absorption retarder, an antioxidant, an antiseptic, a corrigent, a colorant, an odorant, and mixtures thereof.
11. The method of claim 1 , wherein the at least one skin damage is the formation of skin cancer induced by ultraviolet light.
12. The method of claim 1 , wherein the at least one skin damage is the formation of freckles induced by ultraviolet light.
13. The method of claim 1 , wherein the at least one skin damage is the formation of pigmented spots induced by ultraviolet light.
14. The method of claim 1 , wherein the at least one skin damage is the formation of verrucae induced by ultraviolet light.
15. The method of claim 1 , wherein the at least one skin damage is the formation of erythema induced by ultraviolet light.
16. The method of claim 1 , wherein the composition comprises 66.4% diacylglyceryl ether represented by the formula (I), 26.3% triglyceride, and 7.5% squalene.
17. The method of claim 16 , wherein the composition is prepared from degummed shark liver oil.
18. The method of claim 1 , wherein the composition is prepared from degummed shark liver oil.